Literature DB >> 25539623

Gender differences in sensitivity of acetylcholine and ergonovine to coronary spasm provocation test.

Shozo Sueda1, Toru Miyoshi2, Ysuhiro Sasaki2, Tomoki Sakaue2, Hirokazu Habara2, Hiroaki Kohno2.   

Abstract

We examined the sex difference concerning the coronary artery response between ACh and ER in this study. We already reported the difference of coronary response between acetylcholine (ACh) and ergonovine (ER). We performed both ACh and ER tests of 461 patients (male 294 patients, female 167 patients, mean age 64.4 ± 11.3 years) during 23 years. Positive coronary spasm was defined as >99 % transient luminal narrowing with usual chest pain and/or ischemic ECG changes. Firstly, ACh was administered in incremental doses of 20/50/(80) μg into the RCA and 20/50/100/(200) μg into the LCA over 20 s. Secondly, ER was administered in a total dose of 40 μg into the RCA and of 64 μg into the LCA over 2-4 min. Intracoronary injection of ACh and ER provoked spasm in 221 patients consisting of 160 male patients and 61 female patients. In female patients, the spasm provoked by ACh was almost perfect except in two patients (59 patients, 96.7 %), while ER provoked spasm in only 20 patients (32.8 %). In male patients, provoked spasm by ACh (129 patients, 80.6 %) was significantly higher than ER (97 patients, 60.6 %). As a spasm provocation test, ACh is more sensitive than ER in both sexes and especially in females. We may select two pharmacological agents by sex differences to provoke coronary artery spasm in the cardiac catheterization laboratory in the future.

Entities:  

Keywords:  Acetylcholine; Coronary response; Ergonovine; Men; Women

Mesh:

Substances:

Year:  2014        PMID: 25539623     DOI: 10.1007/s00380-014-0614-4

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  22 in total

1.  Major complications during spasm provocation tests with an intracoronary injection of acetylcholine.

Authors:  S Sueda; H Saeki; T Otani; K Mineoi; T Kondou; K Yano; T Ochi; N Ochi; Y Hayashi; T Tsuruoka; H Kawada; S Matsuda; T Uraoka
Journal:  Am J Cardiol       Date:  2000-02-01       Impact factor: 2.778

2.  Clinical characteristics and possible mechanism of paroxysmal atrial fibrillation induced by intracoronary injection of acetylcholine.

Authors:  S Sueda; H Fukuda; K Watanabe; N Ochi; H Kawada; Y Hayashi; T Uraoka
Journal:  Am J Cardiol       Date:  2001-09-01       Impact factor: 2.778

3.  Arterial hypertension. Report of a WHO expert committee.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1978

4.  Safety and optimal protocol of provocation test for diagnosis of multivessel coronary spasm.

Authors:  Shozo Sueda; Toru Miyoshi; Yasuhiro Sasaki; Tomoki Sakaue; Hirokazu Habara; Hiroaki Kohno
Journal:  Heart Vessels       Date:  2014-11-01       Impact factor: 2.037

5.  A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association.

Authors:  W G Austen; J E Edwards; R L Frye; G G Gensini; V L Gott; L S Griffith; D C McGoon; M L Murphy; B B Roe
Journal:  Circulation       Date:  1975-04       Impact factor: 29.690

6.  Clinical characteristics of female patients with coronary spastic angina: comparison with male patients.

Authors:  S Sueda; J Suzuki; K Watanabe; K Mineoi; T Kondou; K Yano; T Ochi; N Ochi; Y Hayashi; H Kukita; S Matsuda; H Kawada; T Tsuruoka; T Uraoka
Journal:  Jpn Circ J       Date:  2000-06

7.  Frequency of provoked coronary spasms in patients undergoing coronary arteriography using a spasm provocation test via intracoronary administration of ergonovine.

Authors:  Shozo Sueda; Hiroaki Kohno; Hiroshi Fukuda; Naoto Ochi; Hiroyuki Kawada; Yutaka Hayashi; Tadao Uraoka
Journal:  Angiology       Date:  2004 Jul-Aug       Impact factor: 3.619

8.  Limitations of medical therapy in patients with pure coronary spastic angina.

Authors:  Shozo Sueda; Hiroaki Kohno; Hiroshi Fukuda; Kouki Watanabe; Naoto Ochi; Hiroyuki Kawada; Tadao Uraoka
Journal:  Chest       Date:  2003-02       Impact factor: 9.410

9.  Induction of coronary artery spasm by two pharmacological agents: comparison between intracoronary injection of acetylcholine and ergonovine.

Authors:  Shozo Sueda; Hiroaki Kohno; Hiroshi Fukuda; Naoto Ochi; Hiroyuki Kawada; Yutaka Hayashi; Tadao Uraoka
Journal:  Coron Artery Dis       Date:  2003-09       Impact factor: 1.439

10.  Frequency of provoked coronary arterial spasm in 1089 consecutive patients undergoing coronary arteriography.

Authors:  M E Bertrand; J M LaBlanche; P Y Tilmant; F A Thieuleux; M R Delforge; A G Carre; P Asseman; B Berzin; C Libersa; J M Laurent
Journal:  Circulation       Date:  1982-06       Impact factor: 29.690

View more
  9 in total

Review 1.  Overview of the Acetylcholine Spasm Provocation Test.

Authors:  Shozo Sueda; Hiroaki Kohno; Takaaki Ochi; Tadao Uraoka
Journal:  Clin Cardiol       Date:  2015-07-14       Impact factor: 2.882

2.  Feasibility and safety of outpatient cardiac catheterization with intracoronary acetylcholine provocation test.

Authors:  Yuichi Saito; Hideki Kitahara; Toshihiro Shoji; Satoshi Tokimasa; Takashi Nakayama; Kazumasa Sugimoto; Yoshihide Fujimoto; Yoshio Kobayashi
Journal:  Heart Vessels       Date:  2018-02-12       Impact factor: 2.037

3.  Differential incidence and morphology of provoked spasm between intracoronary acetylcholine and ergonovine testing: recommendation of supplementary use.

Authors:  Shozo Sueda; Kaori Fujimoto; Yasuhiro Sasaki; Tomoki Sakaue; Toyofumi Yoshii; Hirokazu Habara; Hiroaki Kohno
Journal:  Heart Vessels       Date:  2018-11-24       Impact factor: 2.037

4.  History of gastroesophageal reflux disease in patients with suspected coronary artery disease.

Authors:  Hiroki Teragawa; Chikage Oshita; Tomohiro Ueda
Journal:  Heart Vessels       Date:  2019-04-16       Impact factor: 2.037

5.  Association of epicardial adipose tissue with coronary spasm and coronary atherosclerosis in patients with chest pain: analysis of data collated by the KoRean wOmen'S chest pain rEgistry (koROSE).

Authors:  Mi-Na Kim; Hack-Lyoung Kim; Seong-Mi Park; Mi Seung Shin; Cheol Woong Yu; Myung-A Kim; Kyung-Soon Hong; Wan-Joo Shim
Journal:  Heart Vessels       Date:  2017-08-01       Impact factor: 2.037

6.  Coronary spasm: It's common, but it's still unsolved.

Authors:  Hiroki Teragawa; Chikage Oshita; Tomohiro Ueda
Journal:  World J Cardiol       Date:  2018-11-26

7.  A case report: intracoronary acetylcholine testing without a pacemaker may be one option in the left coronary artery.

Authors:  Shozo Sueda; Tomoki Sakaue
Journal:  Eur Heart J Case Rep       Date:  2021-10-20

8.  Spasm Provocation Test Using Acetylcholine in Patients with Bronchial Asthma: An Important Step Forward.

Authors:  Hiroki Teragawa
Journal:  Intern Med       Date:  2020-08-12       Impact factor: 1.271

Review 9.  Assessment of Vascular Dysfunction in Patients Without Obstructive Coronary Artery Disease: Why, How, and When.

Authors:  Thomas J Ford; Peter Ong; Udo Sechtem; John Beltrame; Paolo G Camici; Filippo Crea; Juan-Carlos Kaski; C Noel Bairey Merz; Carl J Pepine; Hiroaki Shimokawa; Colin Berry
Journal:  JACC Cardiovasc Interv       Date:  2020-08-24       Impact factor: 11.075

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.